Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscous vs Nebulized Budesonide in EoE
NCT00961233Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in eosinophilic esophagitis (EoE), sponsored by University of North Carolina at Chapel Hill. Started Oct 2009; status: completed.
02
Drugs
EPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00961233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961233.